Intranasal Delivery of Influenza rNP Adjuvanted with c-di-AMP Induces Strong Humoral and Cellular Immune Responses and Provides Protection against Virus Challenge-Reference-Cited by-同舟云学术

Intranasal Delivery of Influenza rNP Adjuvanted with c-di-AMP Induces Strong Humoral and Cellular Immune Responses and Provides Protection against Virus Challenge

Published:2014-08-20 Issue:8 Volume:9 Page:e104824
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Sanchez Maria Victoria,Ebensen Thomas,Schulze Kai,Cargnelutti Diego,Blazejewska Paulina,Scodeller Eduardo A.,Guzmán Carlos A.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference68 articles.

1. Interim Within-Season Estimate of the Effectiveness of Trivalent Inactivated Influenza Vaccine — Marshfield, Wisconsin, 2007–08 Influenza Season;E Belongia;MMWR Morb Mortal Wkly Rep,2008

2. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis;MT Osterholm;Lancet Infect Dis,2012

3. Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults;TG Boyce;Vaccine,2000

4. Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa;KA Brokstad;J Infect Dis,2002

5. Augmentation of human influenza A virus-specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS);FA Ennis;Virology,1999

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intranasal Vaccination with Recombinant TLR2-Active Outer Membrane Vesicles Containing Sequential M2e Epitopes Protects against Lethal Influenza a Challenge;Vaccines;2024-06-29

2. Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines;Vaccines;2023-11-23

3. Immune responses following neonatal vaccination with conserved F4 fragment of VtaA proteins from virulent Glaesserella parasuis adjuvanted with CAF®01 or CDA;Vaccine: X;2023-08

4. Pulmonary Application of Novel Antigen-Loaded Chitosan Nano-Particles Co-Administered with the Mucosal Adjuvant C-Di-AMP Resulted in Enhanced Immune Stimulation and Dose Sparing Capacity;Pharmaceutics;2023-04-13

5. Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based on the Recombinant Nucleoprotein Co-Administered with a TLR2/6 Agonist BPPcysMPEG;Pharmaceutics;2023-03-10